784 39 13119 7 39355 document 13119 Underreporing_web_supplements_3-20_revision_final.xlsx application/vnd.openxmlformats-officedocument.spreadsheetml.sheet 46842d9526d8a32f8269622bbcd4ef42 MD5 379267 2020-04-03 17:04:56 https://researchdata.bath.ac.uk/784/1/Underreporing_web_supplements_3-20_revision_final.xlsx 784 1 1 application/vnd.openxmlformats-officedocument.spreadsheetml.sheet other en public cc_by

Underreporing_web_supplements_3-20_revision_final.xlsx

data archive 4224 disk0/00/00/07/84 2020-07-10 12:58:34 2024-07-02 14:49:08 2020-07-10 12:58:34 data_collection show Ozieranski Piotr P.Ozieranski@bath.ac.uk 0000-0002-2023-3288 University of Bath TRUE Csanadi Marcell marcell.csanadi@syreon.eu 0000-0002-5724-639X Syreon Research Institute FALSE Rickard Emily ejr29@bath.ac.uk 0000-0003-2251-0127 University of Bath FALSE Mulinari Shai shai.mulinari@soc.lu.se 0000-0001-8773-9796 Lund University FALSE JT0010 JZ0010 dept_soc_sci pharmaceutical industry, patient organisations, payments, transparency, accountability The data is organised into 17 appendices which correspond with specific parts of the Results section of the paper entitled "An underreported relationship: a comparative study of pharmaceutical industry and patient organisation payment disclosures in the UK (2012-2016)". This online dataset comprises web supplements (WS) accompanying the paper entitled “An underreported relationship: a comparative study of pharmaceutical industry and patient organisation payment disclosures in the UK (2012-2016)”. The dataset includes aggregated information from 1. yearly disclosure reports published by 63 UK-based drug companies including payments made to patient organisations; 2. yearly financial accounts produced by 200 UK-based charities and published on charity regulator websites. The data is divided into web supplements 3-20 which are signposted throughout the Results section of the above-mentioned article as “web supplement XX”. 2020-07-10 University of Bath public RightsHolder University of Bath Swedish Research Council for Health, Working Life and Welfare https://doi.org/10.13039/501100006636 2016-00875 What can be learnt from the new pharmaceutical industry payment disclosures? cent_casp The methodology is described in full in the Data sources and extraction section of the paper entitled "An underreported relationship: a comparative study of pharmaceutical industry and patient organisation payment disclosures in the UK (2012-2016)". In brief, the data collection process involved downloading disclosure reports including payments to patient organisations made by a sample of 108 companies participating in the Disclosure UK initiative in 2016 (https://www.abpi.org.uk/our-ethics/disclosure-uk/). We subsequently searched for the annual accounts of patient organisations identified in drug company payment disclosure reports on the websites of the three UK charity regulators, that is the Charity Commission for England and Wales (https://www.gov.uk/government/organisations/charity-commission), the Scottish Charity Regulator (https://www.oscr.org.uk/) and the Charity Commission for Northern Ireland (https://www.charitycommissionni.org.uk/). The payment data from drug company payment disclosure reports and charity annual accounts was extracted into two separate Excel spreadsheets. We subsequently combined payment records form the two spreadsheets into a single excel spreadsheet comprising a series of drug company by patient organisation matrices corresponding with different types of analysis carried out as part of our research study. In total, this online dataset comprises 17 web supplements with the results of calculations based on these matrices. The web supplements correspond with and provide additional background information for specific subsections in the Results section of the article entitled "An underreported relationship: a comparative study of pharmaceutical industry and patient organisation payment disclosures in the UK (2012-2016)". The data was created using Excel (primarily "countifs", "sumifs", and "V-lookup" functions) en 1 10.15125/BATH-00784 https://doi.org/10.1136/bmjopen-2020-037351 pub open